Aguirre-Plans, J., Pinero, J., Menche, J., Sanz, F., Furlong, L. I., Schmidt, H. H. H. W., ... Guney, E. (2018). Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases via Network Endopharmacology. Pharmaceuticals, 11(3), [61]. DOI: 10.3390/ph11030061

Egea, J., Fabregat, I., Frapart, Y. M., Ghezzi, P., Gorlach, A., Kietzmann, T., ... Daiber, A. (2018). European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) (vol 13, pg 94, 2017). Redox Biology, 14, 694-696. DOI: 10.1016/j.redox.2017.10.001

Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M., Barbas, C., Daiber, A., ... Schmidt, H. H. H. W. (2018). Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. Pharmacological Reviews, 70(2), 348-383. DOI: 10.1124/pr.117.014753

Casas, A. I., Geuss, E., Kleikers, P. W. M., Mencl, S., Herrmann, A. M., Buendia, I., ... Schmidt, H. H. H. W. (2017). NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage. Proceedings of the National Academy of Sciences of the United States of America, 114(46), 12315-12320. DOI: 10.1073/pnas.1705034114

Egea, J., Fabregat, I., Frapart, Y. M., Ghezzi, P., Gorlach, A., Kietzmann, T., ... Daiber, A. (2017). European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biology, 13, 94-162. DOI: 10.1016/j.redox.2017.05.007

Vonbank, A., Agewall, S., Kjeldsen, K. P., Lewis, B. S., Torp-Pedersen, C., Ceconi, C., ... Drexel, H. (2017). Comprehensive efforts to increase adherence to statin therapy. European Heart Journal, 38(32), 2473-2477b. DOI: 10.1093/eurheartj/ehw628

Ghezzi, P., Jaquet, V., Marcucci, F., & Schmidt, H. H. H. W. (2017). The oxidative stress theory of disease: levels of evidence and epistemological aspects. British Journal of Pharmacology, 174(12), 1784-1796. DOI: 10.1111/bph.13544

Gray, S. P., Jha, J. C., Kennedy, K., van Bommel, E., Chew, P., Szyndralewiez, C., ... Jandeleit-Dahm, K. A. M. (2017). Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease. Diabetologia, 60(5), 927-937. DOI: 10.1007/s00125-017-4215-5

Geis, C., Geuss, E., Sommer, C., Schmidt, H. H. H. W., & Kleinschnitz, C. (2017). NOX4 is an early initiator of neuropathic pain. Experimental Neurology, 288, 94-103. DOI: 10.1016/j.expneurol.2016.11.008

Kleinschnitz, C., Mencl, S., Kleikers, P. W. M., Schuhmann, M. K., Lopez, M. G., Casas, A. I., ... Schmidt, H. H. H. W. (2016). NOS knockout or inhibition but not disrupting PSD-95-NOS interaction protect against ischemic brain damage. Journal of Cerebral Blood Flow and Metabolism, 36(9), 1508-1512. DOI: 10.1177/0271678X16657094